These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2623200)

  • 1. The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population.
    Yuan B; Klein MH; Contiguglia RS; Mishell JL; Seligman PA; Miller NL; Molitoris BA; Alfrey AC; Shapiro JI
    Ren Fail; 1989; 11(2-3):91-6. PubMed ID: 2623200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.
    Bia MJ; Cooper K; Schnall S; Duffy T; Hendler E; Malluche H; Solomon L
    Kidney Int; 1989 Nov; 36(5):852-8. PubMed ID: 2615192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R; Dombrouski J; Burnatowska-Hledin M; Mayor G
    Am J Kidney Dis; 1987 Mar; 9(3):217-23. PubMed ID: 3826071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell aluminum in patients with renal failure and effect of desferrioxamine infusion.
    Umeda M; Tsurusaki K; Kamikawa S; Izumi N; Yasumoto R; Kishimoto T; Maekawa M
    Blood Purif; 1990; 8(5):295-300. PubMed ID: 2091689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desferrioxamine infusion on red blood cell aluminum.
    Umeda M; Umimoto K; Tsurusaki K; Izumi N; Kishimoto T; Maekawa M
    ASAIO Trans; 1988; 34(3):297-9. PubMed ID: 3196524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate.
    Abreo K; Brown ST; Sella M
    Am J Kidney Dis; 1989 Jun; 13(6):465-8. PubMed ID: 2729267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum overload in the reverse osmosis dialysis era: does it exist?
    Chen MY; Ou SH; Chen NC; Yin CH; Chen CL
    Ren Fail; 2022 Dec; 44(1):1595-1603. PubMed ID: 36190833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Coburn JW; Norris KC
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):12-21. PubMed ID: 3299588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
    Wang G; Zhu P; Wang S
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):36-40. PubMed ID: 9275645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate.
    O'Hare JA; Murnaghan DJ
    N Engl J Med; 1982 Mar; 306(11):654-6. PubMed ID: 7057824
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication.
    Caramelo CA; Cannata JB; Rodeles MR; Fernández Martín JL; Mosquera JR; Monzú B; Outeiriño J; Blum G; Andrea C; Lopez Farré AJ
    Kidney Int; 1995 Jan; 47(1):164-8. PubMed ID: 7731142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An effect of aluminum on hemesynthesis--special reference to erythrocyte uroporphyrinogen--1--Synthetase and protoporphyrin].
    Okajima E; Sasaki K; Ohara S; Yosida K; Kaneko Y; Motomiya Y; Hirao Y
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):161-6. PubMed ID: 2051643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an iron supplement on serum aluminum level and desferrioxamine mobilization test in hemodialysis patients.
    Huang JY; Wu MS; Wu CH
    Ren Fail; 2001 Nov; 23(6):789-95. PubMed ID: 11777318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients].
    Nakazawa R
    Clin Calcium; 2004 May; 14(5):738-43. PubMed ID: 15577035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].
    Seidowsky A; Dupuis E; Drueke T; Dard S; Massy ZA; Canaud B
    Nephrol Ther; 2018 Feb; 14(1):35-41. PubMed ID: 29174672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.